Interim results from the IMPACT study: evidence for PSA screening in BRCA2 mutation carriers
Year: 2019
Session type: Proffered paper sessions
Theme: Early detection, diagnosis and prognosis
1The Institute of Cancer Research, London, UK,2The Institute of Cancer Research,3Royal Marsden NHS Foundation Trust, London, UK,4Memorial Sloan Kettering Cancer Center, New York, US,5King’s College London, London, UK,6the Institute of Cancer Research